$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Nov 14, 2025)
$292.50M
Market Cap
-
P/E Ratio
-
EPS
$45.00
52 Week High
$9.81
52 Week Low
HEALTHCARE
Sector
| Field | Value |
|---|---|
| Ex Dividend Date | 2023-01-13 |
| Declaration Date | None |
| Record Date | None |
| Payment Date | None |
| Amount | 0.24 |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Crescent Biopharma, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to developing innovative protease therapeutics that target hemostasis and complement regulation. The company is poised to address significant unmet medical needs through its promising pipeline, which includes novel candidates designed to tackle serious conditions associated with blood coagulation and immune response. Leveraging advanced research and proprietary technologies, Crescent Biopharma aims to deliver transformative solutions within the biopharmaceutical sector, positioning itself as a key player in the evolving landscape of therapeutic advancements.
LPTX
ASBP
EPWK
VHAI
NVDA
IVVD
BYND
ASST
TSLA
SOFI
BITF
PLUG
PFE
PLTR
RGTI
INTC
ADAP
TLRY
F
QBTS
NIO
CIFR
SNAP
IREN
DNN
AMD
DVLT
SMCI
WULF
MARA
WBD
APLT
CLSK
APLD
ORCL
GRAB
CAN
MTSR
MU
PLTD
HOOD
HIMS
NBIS
CSCO
BABA
KDLY
NOK
T
IONQ
SOUN
BTBT
JD
RIG
GOOGL
RIOT
BAC
QS
DFLI
AAL
RXRX
PCG
LYFT
BE
LAES
VZ
PSNY
KLG
LPTX
ASBP
EPWK
VHAI
NVDA
IVVD
BYND
ASST
TSLA
SOFI
BITF
PLUG
PFE
PLTR
RGTI
INTC
ADAP
TLRY
F
QBTS
NIO
CIFR
SNAP
IREN
DNN
AMD
DVLT
SMCI
WULF
MARA
WBD
APLT
CLSK
APLD
ORCL
GRAB
CAN
MTSR
MU
PLTD
HOOD
HIMS
NBIS
CSCO
BABA
KDLY
NOK
T
IONQ
SOUN
BTBT
JD
RIG
GOOGL
RIOT
BAC
QS
DFLI
AAL
RXRX
PCG
LYFT
BE
LAES
VZ
PSNY
KLG